NCT03458767

Brief Summary

Development and pilot testing of a cognitive self-management intervention for persons with multiple sclerosis (PwMS) emphasizing physical activity (PA) delivered via web-based video conference.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 9, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 21, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

July 17, 2018

Status Verified

July 1, 2018

Enrollment Period

8 months

First QC Date

November 21, 2017

Last Update Submit

July 13, 2018

Conditions

Keywords

Cognitive functionPhysical activitySelf-management

Outcome Measures

Primary Outcomes (8)

  • Change from Baseline NIH Toolbox Picture Vocabulary Test at 8-weeks (post-intervention)

    Test of vocabulary knowledge

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox Oral Reading Recognition at 8-weeks (post-intervention)

    Test of oral reading (decoding) skills

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox Flanker Inhibitory Control and Attention Test at 8-weeks (post-intervention)

    Test of executive function - the capacity to plan, organize and monitor the execution of behaviors that are strategically directed in a goal-oriented manner) and attention (allocation of one's limited capacities to deal with an abundance of environmental stimulation) test.

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox Dimensional Change Card Sort Test at 8-weeks (post-intervention)

    Test of attention - the allocation of one's limited capacities to deal with an abundance of environmental stimulation) test.

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox List Sorting Working Memory Test at 8-weeks (post-intervention)

    Test of working memory - the capacity of an individual to hold information in a short-term buffer and manipulate the information.

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox Oral Symbol Digit Test at 8-weeks (post-intervention)

    Test of processing speed - the amount of time it takes to mentally process a set amount of information, or the amount of information that can be processed within a certain unit of time. It is a measure that reflects mental efficiency.

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox Pattern Comparison Processing Speed Test at 8-weeks (post-intervention)

    Test of processing speed - the amount of time it takes to mentally process a set amount of information, or the amount of information that can be processed within a certain unit of time. It is a measure that reflects mental efficiency.

    Baseline and 8-weeks (post intervention)

  • Change from Baseline NIH Toolbox Picture Sequence Memory Test at 8-weeks (post-intervention)

    Test of episodic memory - the acquisition, storage and retrieval of new information. It involves conscious recollection of information learned within a context.

    Baseline and 8-weeks (post intervention)

Secondary Outcomes (14)

  • Change from Baseline Multiple Sclerosis Self-Management Scale (MSSM) at 8-weeks (post-intervention)

    Baseline and 8-weeks (post intervention)

  • Change from Baseline PROMIS Short Form v1.0 - Self-Efficacy for Managing Medications and Treatments 4a at 8-weeks (post-intervention)

    Baseline and 8-weeks (post intervention)

  • Change from Baseline PROMIS Short Form v1.0 - Self-Efficacy for Managing Symptoms 4a at 8-weeks (post-intervention)

    Baseline and 8-weeks (post intervention)

  • Change from Baseline PROMIS Short Form v1.0 - Self-Efficacy for Managing Daily Activities 4a at 8-weeks (post-intervention)

    Baseline and 8-weeks (post intervention)

  • Change from Baseline Neuro-Quality of Life (QoL) Short Form v2.0 - Cognitive Function at 8-weeks (post-intervention)

    Baseline and 8-weeks (post intervention)

  • +9 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Eight weekly 90-minute group educational sessions attended via a computer, tablet, or smart phone using a web-based video conference platform.

Behavioral: Eight weekly 90-minute group educational sessions

Control group

NO INTERVENTION

Enhanced usual care control group will receive an illustrated instructional booklet on Physical Activity for persons with MS developed by the National Center on Health, Physical Activity and Disability (NCHPAD).

Interventions

Eight weekly 90-minute group educational sessions, originally developed for the MAPSS-MS intervention, adapted for remote web-based delivery.

Intervention group

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of clinically definite MS documented by their healthcare provider
  • Age 21 to 70
  • Capable of understanding and complying with the study protocol
  • Able to read and write in English
  • Stable disease at the time of entry into the study (relapse free for at least 90 days)
  • Willing to participate in an 8-week study promoting physical activity, MS self-management and compensatory cognitive strategies, and data collection
  • Have subjective concerns about their cognitive functioning (score ≥ 10 on the 20-item Perceived Deficits Questionnaire)
  • Any gender
  • Any ethnic/racial group

You may not qualify if:

  • Currently pregnant or plan to be
  • Diagnosed with cardiovascular or respiratory disease, other medical causes of dementia or other neurological disorders that may impact cognition or emotions
  • Evidence of major psychiatric disorder
  • Major functional limitations that preclude them from participating in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas at Austin

Austin, Texas, 78701, United States

Location

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Officials

  • Janet D Morrison, PhD

    The University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
A trained research assistant, blinded to the participant's group assignment, will collect the NIH Toolbox measures using an iPad at baseline and 8-weeks (post-intervention).
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This pilot feasibility study employs a mixed methods design conducted in a community setting. Phase 1 uses a single-group qualitative design involving a convenience sample of 5 adults with MS; Phase 2 uses a randomized controlled trial (RCT) design conducted with a sample of 20 adults with MS (10 intervention/10 control). Phase 2 data will be collected at baseline (before the intervention) and at 8-weeks (post-intervention). Data includes self-report measures, an objective measure of physical activity, and neurocognitive tests. An "enhanced usual care" control group is selected as most appropriate for this pilot feasibility study of a non-pharmacologic, behavioral intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2017

First Posted

March 8, 2018

Study Start

October 9, 2017

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

July 17, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data from this pilot study

Locations